This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
5 Hospital Stocks Set to Thrive Amid Robust Industry Trends
by Zacks Equity Research
The Zacks Medical-Hospital industry is likely to gain from rising patient admissions and technological advancements. Companies like HCA, THC, UHS, ACHC and CYH are poised to gain from these trends.
A Dose of Growth? Why Tenet Healthcare Could be a Buy Pre-Q3 Earnings
by Kaibalya Pravo Dey
THC's third-quarter results are likely to reflect growing patient admissions, utilization and patient days.
Community Health Q3 Earnings Miss on Lower Adjusted Admissions
by Zacks Equity Research
CYH's third-quarter earnings suffer a setback due to lower admissions and patient days. Improved occupancy levels and reimbursement rates partially offset the negatives.
Compared to Estimates, Community Health Systems (CYH) Q3 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Community Health Systems (CYH) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Community Health Systems (CYH) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Community Health Systems (CYH) delivered earnings and revenue surprises of -87.50% and 0.25%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Community Health Systems (CYH) Is Attractively Priced Despite Fast-paced Momentum
by Zacks Equity Research
Community Health Systems (CYH) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Brookdale Q3 2024 Occupancy Jumps, Logs 35th Straight Monthly Boost
by Zacks Equity Research
BKD's weighted average occupancy for September grows 30 bps sequentially.
Community Health Teams Up With Denim to Scale Conversational AI
by Zacks Equity Research
With this move, CYH intends to streamline agent workload, which can result in more savings for the company.
Does Universal Health's Low P/E Ratio Signal a Suitable Entry Point?
by Debasmita Chatterjee
UHS rides on increased patient volumes. It can effectively cater to its patients through its extensive treatment network.
Community Health's Arm Northwest Urgent Buys 10 Arizona Facilities
by Zacks Equity Research
CYH expects the acquisition from Carbon Health to be completed in the fourth quarter of 2024.
Why Is Community Health Systems (CYH) Up 2.3% Since Last Earnings Report?
by Zacks Equity Research
Community Health Systems (CYH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks Industry Outlook Highlights HCA Healthcare, Universal Health Services, Tenet Healthcare, Acadia Healthcare and Community Health Systems
by Zacks Equity Research
HCA Healthcare, Universal Health Services, Tenet Healthcare, Acadia Healthcare and Community Health Systems have been highlighted in this Industry Outlook article.
5 Hospital Stocks Poised to Benefit From Strong Industry Growth
by Kaibalya Pravo Dey
The Zacks Medical-Hospital industry will gain from increasing admissions and cybersecurity and technological advancements. Companies like HCA, UHS, THC, ACHC and CYH are poised to gain from these trends.
Community Health (CYH) Q2 Earnings Miss on Lower Patient Days
by Zacks Equity Research
Community Health's (CYH) second-quarter earnings suffer a setback from lower admissions and patient days. Improved occupancy levels partially offset the negatives.
Compared to Estimates, Community Health Systems (CYH) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Community Health Systems (CYH) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Community Health Systems (CYH) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Community Health Systems (CYH) delivered earnings and revenue surprises of -54.55% and 1.96%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Can These 3 Hospital Stocks Beat Q2 Earnings Expectations?
by Kaibalya Pravo Dey
Rising patient volumes, admission and occupancy levels are expected to have benefited hospital players in the second quarter, partly offset by higher costs. THC, UHS and CYH will release earnings on Jul 24.
Buying Tenet (THC) Pre-Q2 Earnings: A Prescription for Profits?
by Kaibalya Pravo Dey
Tenet Healthcare's (THC) second-quarter earnings are likely to have benefited from higher admissions, average length of stay and patient days.
Community Health (CYH) & Cost Plus Drugs Expand Collaboration
by Zacks Equity Research
Community Health (CYH) is now set to source drugs from the Cost Plus Drugs Marketplace under the new expanded partnership.
Zacks Industry Outlook Highlights HCA Healthcare, Tenet Healthcare, Universal Health Services, Acadia Healthcare and Community Health Systems
by Zacks Equity Research
HCA Healthcare, Tenet Healthcare, Universal Health Services, Acadia Healthcare and Community Health Systems are part of the Zacks Industry Outlook article.
5 Hospital Stocks Set to Gain From Robust Industry Trends
by Kaibalya Pravo Dey
The Zacks Medical-Hospital industry is gaining from growing patient volumes, utilization rates and technological advancements. Companies like HCA, THC, UHS, ACHC and CYH are expected to gain from these trends.
Community Health Systems (CYH) Up 9.2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Community Health Systems (CYH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Community Health (CYH) Q1 Earnings Top on Better Occupancy Rates
by Zacks Equity Research
Community Health's (CYH) first-quarter results benefit from improved occupancy and reimbursement rates. However, declining admissions partially offset the positives.
Here's What Key Metrics Tell Us About Community Health Systems (CYH) Q1 Earnings
by Zacks Equity Research
Although the revenue and EPS for Community Health Systems (CYH) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Community Health Systems (CYH) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Community Health Systems (CYH) delivered earnings and revenue surprises of 26.32% and 1.49%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?